Join industry experts live at Eyes On Retina 2025
Step into a full day of virtual retina education on Saturday, October 4! Earn up to 5 free CE/CME credits as you discover new data, challenge your instincts, and solve complex retinal mysteries alongside world-renowned speakers.
New Content
Understanding & Managing Astigmatism Series: Toric Multifocal Optimization
Fitting the Right Patient with the Right Contact Lens with Step-By-Step Flowchart
Eyes On Eyecare Site Sponsors
Understanding Wetting Agents in Contact Lenses
Discover the ins and outs of wetting agents and how optometrists can match patients with the best option to keep them comfortable in their lenses.
Advancing the Retina Pipeline: Insights into Drug Development
Join John W. Kitchens, MD, and Peter K. Kaiser, MD, as they review how to get involved in drug development and advances in the retina pipeline.
2025 Specialty Contact Lens Report
We surveyed over 580 optometrists on their utilization of specialty contact lenses. Download your free copy of the report to learn how your colleagues are incorporating scleral lenses, ortho-K, hybrid lenses, and more into their practices!
Topics
A Curious Case of Aggressive Geographic Atrophy in Wet AMD
Conjunctivochalasis: When to Intervene
Join Jerry Robben, OD, and Damon Dierker, OD, FAAO, for a discussion of how to identify and treat conjunctivochalasis in patients with concomitant dry eye.
CMS assigns permanent J-code for Neurotech's ENCELTO cell therapy
The allogeneic encapsulated cell-based therapy is the first and only treatment approved by the FDA for the treatment of MacTel.
National trial to test preventative atropine drops for pediatric myopia
The University of Houston and The Ohio State University researchers partner on NEI-funded study to test if low-concentrated drops delay onset of myopia.
Are corneal dystrophies linked to mental health conditions?
Study highlights the importance of assessing corneal dystrophy patients’ psychological well-being.
Leadership update: SpyGlass, Lumata Health, and Horizon Surgical report changes
Understanding & Managing Astigmatism Series: Toric Multifocal Optimization
Kurt Moody, OD, FAAO, FBCLA, Dipl, CCLRT, and Erin Rueff, OD, PhD, FAAO, Dipl, explore the nuances of correcting presbyopic astigmatic refractive error with contact lenses and examine the emerging products for these cases—and the considerations you need to make when deciding whether to prescribe them to your astigmatic patients.
The Collaborative Dynamic in Geographic Atrophy Care
Review a case report of geographic atrophy (GA), key anatomic features to monitor on imaging, and how to optimize collaborative care for GA patients.
Fitting the Right Patient with the Right Contact Lens with Step-By-Step Flowchart
Learn how optometrists can match patients with the best contact lens for their needs and fit them correctly the first time around, and download the flowchart!
Clinical Specialties
Advancing the Retina Pipeline: Insights into Drug Development
2025 Specialty Contact Lens Report
How to Reduce Monthly Costs in Your Optometry Practice
Learn how to budget for an optometry practice to optimize finances and download the cheat sheet to guide the process!
A Comprehensive Guide to Acing Your Optometry Residency Application
This guide to residency, the application process, and timeline will give you a great head start in applying for an optometry residency. Check out the checklist below!
How Optometry Students Should...and Should Not...Utilize AI
Learn best practices for optometry students to ethically utilize artificial intelligence (AI) to enhance optometric education.
Careers
Top Optometry Podcasts for Every Eyecare Practitioner
3 Leading Ophthalmologists Weigh In On Opening a Practice
The Ultimate Guide to ABB Verify
Managing Ocular Adverse Effects of Treatment for Platinum-Resistant Ovarian Cancer
The following article will investigate ELAHERE® (mirvetuximab soravtansine-gynx), a medication used to treat platinum-resistant epithelial ovarian, fallopian, and primary peritoneal cancer, and how eye care professionals (ECPs) can address ocular events seen and managed across ELAHERE® trials.
